Josh Thomas Georgy, Soumya Susan Regi, Rosh Varghese Georgy, Balu Krishna Sasidharan, Anjana Joel, Deepa Susan Joy Philip, Ajoy Oommen John, Divya Bala Thumaty, Praveen Kumar Marimuthu, Prashant Jambunathan, Kovilapu Harikrishna, Zachariah Thomas, N. Jansi Rani, Amit Jiwan Tirkey, Meera Thomas, Rajesh Isiah, Ashish Singh. "Low-dose nivolumab plus induction chemotherapy for locally advanced or unresectable head and neck cancer is associated with high response rates and conversion to definitive therapy." Scientific Reports, 2025. doi:10.1038/s41598-025-19197-y